Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $59.1 Million - $73.3 Million
-270,087 Reduced 53.45%
235,266 $63.2 Million
Q2 2023

Aug 04, 2023

SELL
$214.27 - $253.37 $2.55 Million - $3.01 Million
-11,895 Reduced 2.3%
505,353 $112 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $1.72 Million - $2.1 Million
7,622 Added 1.5%
517,248 $125 Million
Q4 2022

Feb 03, 2023

BUY
$229.03 - $291.01 $2.31 Million - $2.94 Million
10,094 Added 2.02%
509,626 $134 Million
Q3 2022

Nov 04, 2022

SELL
$224.46 - $253.15 $5.08 Million - $5.73 Million
-22,641 Reduced 4.34%
499,532 $113 Million
Q2 2022

Aug 05, 2022

SELL
$230.71 - $256.74 $2.32 Million - $2.58 Million
-10,037 Reduced 1.89%
522,173 $127 Million
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $583,258 - $645,236
-2,660 Reduced 0.5%
532,210 $129 Million
Q4 2021

Feb 04, 2022

BUY
$198.88 - $227.6 $317,810 - $363,704
1,598 Added 0.3%
534,870 $120 Million
Q3 2021

Nov 05, 2021

SELL
$212.27 - $248.7 $14.4 Million - $16.8 Million
-67,648 Reduced 11.26%
533,272 $113 Million
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $13 Million - $14.5 Million
55,824 Added 10.24%
600,920 $146 Million
Q1 2021

May 07, 2021

BUY
$221.91 - $258.6 $6.93 Million - $8.08 Million
31,246 Added 6.08%
545,096 $136 Million
Q4 2020

Feb 05, 2021

BUY
$216.38 - $257.67 $2.59 Million - $3.09 Million
11,973 Added 2.39%
513,850 $118 Million
Q3 2020

Oct 30, 2020

SELL
$234.65 - $260.95 $7.91 Million - $8.79 Million
-33,694 Reduced 6.29%
501,877 $128 Million
Q2 2020

Jul 31, 2020

SELL
$197.81 - $242.74 $112 Million - $137 Million
-564,766 Reduced 51.33%
535,571 $126 Million
Q1 2020

May 01, 2020

SELL
$182.24 - $241.7 $38.1 Million - $50.5 Million
-208,970 Reduced 15.96%
1,100,337 $223 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $18.9 Million - $24.3 Million
100,033 Added 8.27%
1,309,307 $316 Million
Q3 2019

Nov 01, 2019

SELL
$174.11 - $208.62 $2.1 Million - $2.51 Million
-12,046 Reduced 0.99%
1,209,274 $234 Million
Q2 2019

Aug 02, 2019

BUY
$166.7 - $195.41 $45.2 Million - $53 Million
271,301 Added 28.56%
1,221,320 $225 Million
Q1 2019

May 03, 2019

SELL
$180.87 - $203.88 $46.6 Million - $52.5 Million
-257,449 Reduced 21.32%
950,019 $180 Million
Q4 2018

Feb 08, 2019

SELL
$178.4 - $208.25 $65 Million - $75.8 Million
-364,082 Reduced 23.17%
1,207,468 $235 Million
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $1.21 Million - $1.37 Million
-6,549 Reduced 0.41%
1,571,550 $326 Million
Q2 2018

Aug 03, 2018

BUY
$166.05 - $186.51 $39.3 Million - $44.2 Million
236,788 Added 17.65%
1,578,099 $291 Million
Q1 2018

May 04, 2018

BUY
$169.43 - $198.0 $227 Million - $265 Million
1,339,623 Added 79361.55%
1,341,311 $229 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $73,086 - $81,659
433 Added 34.5%
1,688 $294,000
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $209,948 - $239,705
1,255
1,255 $234,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track Richard Pzena's Portfolio

Track Richard Pzena Portfolio

Follow Richard Pzena (Pzena Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.